et al. Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J. Intern. Med.
271, 353–365 (2012).
et al. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat. Genet.
44, 426–429 (2012).
et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet.
41, 1122–1126 (2009).
et al. Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat. Genet.
44, 1231–1235 (2012).
Amin Al Olama, A.
et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum. Mol. Genet.
22, 408–415 (2013).
et al. A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Nat. Genet.
44, 1326–1329 (2012).
et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet.
42, 570–575 (2010).
et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum. Genet.
129, 687–694 (2011).
et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol. Biomarkers Prev.
17, 2052–2061 (2008).
et al. Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res.
70, 2389–2396 (2010).
et al. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population. Clin. Cancer Res.
16, 5244–5251 (2010).
et al. An illegitimate microRNA target site within the 3′ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res.
70, 9641–9649 (2010).
ENCODE Project Consortium. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol.
9, e1001046 (2011).
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature
489, 57–74 (2012).
et al. Genome-wide association studies identify four ER negative–specific breast cancer risk loci. Nat. Genet. published online; doi:10.1038/ng.2561 (27 March 2013).
et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet.
9, e1003212 (2013).
et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA
103, 2257–2261 (2006).
et al. Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy. Int. J. Cancer
128, 1486–1492 (2011).
et al. Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol.
302, L746–L754 (2012).
et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet.
41, 579–584 (2009).
et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. published online; doi:10.1038/ng.2563 (27 March 2013).
et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat. Genet.
43, 570–573 (2011).
et al. Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome. Oncol. Rep.
23, 1045–1052 (2010).
et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol. Cell
36, 405–416 (2009).
et al. Germline mutations in HOXB13 and prostate-cancer risk. N. Engl. J. Med.
366, 141–149 (2012).
et al. Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br. J. Cancer
92, 376–381 (2005).
et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet.
44, 685–689 (2012).
Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J. Natl. Cancer Inst.
91, 1310–1316 (1999).
et al. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet. Epidemiol.
35, 549–556 (2011).
et al. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum. Mol. Genet.
20, 3867–3875 (2011).
et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet.
39, 906–913 (2007).
et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet.
40, 316–321 (2008).
Aulchenko, Y.S., Struchalin, M.V. & van Duijn, C.M.
ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics
11, 134 (2010).
et al. A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics
23, 2741–2746 (2007).
et al. GenoSNP: a variational Bayes within-sample SNP genotyping algorithm that does not require a reference population. Bioinformatics
24, 2209–2214 (2008).
Haldane, J.B. & Slater, E.
Assortative mating. Eugen. Rev.
38, 103 (1946).
Aulchenko, Y.S., Ripke, S., Isaacs, A. & van Duijn, C.M.
GenABEL: an R library for genome-wide association analysis. Bioinformatics
23, 1294–1296 (2007).